A A Volkova, R A Kalyokin, A M Orlova, O G Astashkina, A Z Pavlova
{"title":"[Measurement of benzodiazepine receptor agonists metabolites and their concentration in urine].","authors":"A A Volkova, R A Kalyokin, A M Orlova, O G Astashkina, A Z Pavlova","doi":"10.17116/sudmed20236601128","DOIUrl":null,"url":null,"abstract":"<p><p>The study objective was to detect and measure the ratio of metabolites of benzodiazepine receptor agonists in urine during forensic chemical and chemical and toxicological studies, as well as to characterize the main metabolites to use them to confirm the oral intake of the test substances. Data on the presence of metabolites in the urine will allow us to reliably confirm the intake of zaleplon, zopiclone, clobazam, and phenazepam and determine the routes of administration (intake) into the body of the victim. Benzodiazepine derivatives (clobazam and phenazepam) and non-benzodiazepines (zaleplon and zopiclone) have different chemical structures and similar mechanisms of action resulting in a similar clinical presentation of side effects and the need for forensic chemical study according to poisoning symptoms. Metabolites of benzodiazepine receptor agonists and their ratio in urine after oral administration were measured: zaleplon (parent compound), deethylzaleplon, 5-oxozaleplon, 5-oxodeethylzaleplon, oxozaleplon glucuronide; zopiclone (parent compound), zopiclone-N-oxide, N-desmethylzopiclone; clobazam (parent compound), N-desmethylclobazam, 4-hydroxyclobazam, hydroxydesmethylclobazam; phenazepam (parent compound) and 3-hydroxyphenazepam. It is advisable to determine zaleplon in urine by the presence of 5-oxaleplon (97% of the total amount of metabolites), zopiclone by zopiclone-N-oxide (86% in urine), clobazam by the parent compound (61% in urine), phenazepam by the parent compound (90-100% in urine).</p>","PeriodicalId":35704,"journal":{"name":"Sudebno-Meditsinskaya Ekspertisa","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sudebno-Meditsinskaya Ekspertisa","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17116/sudmed20236601128","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
The study objective was to detect and measure the ratio of metabolites of benzodiazepine receptor agonists in urine during forensic chemical and chemical and toxicological studies, as well as to characterize the main metabolites to use them to confirm the oral intake of the test substances. Data on the presence of metabolites in the urine will allow us to reliably confirm the intake of zaleplon, zopiclone, clobazam, and phenazepam and determine the routes of administration (intake) into the body of the victim. Benzodiazepine derivatives (clobazam and phenazepam) and non-benzodiazepines (zaleplon and zopiclone) have different chemical structures and similar mechanisms of action resulting in a similar clinical presentation of side effects and the need for forensic chemical study according to poisoning symptoms. Metabolites of benzodiazepine receptor agonists and their ratio in urine after oral administration were measured: zaleplon (parent compound), deethylzaleplon, 5-oxozaleplon, 5-oxodeethylzaleplon, oxozaleplon glucuronide; zopiclone (parent compound), zopiclone-N-oxide, N-desmethylzopiclone; clobazam (parent compound), N-desmethylclobazam, 4-hydroxyclobazam, hydroxydesmethylclobazam; phenazepam (parent compound) and 3-hydroxyphenazepam. It is advisable to determine zaleplon in urine by the presence of 5-oxaleplon (97% of the total amount of metabolites), zopiclone by zopiclone-N-oxide (86% in urine), clobazam by the parent compound (61% in urine), phenazepam by the parent compound (90-100% in urine).
本研究的目的是在法医化学和化学毒理学研究中检测和测量尿液中苯二氮卓受体激动剂代谢物的比例,并对主要代谢物进行表征,以确定试验物质的口服摄入。尿液中代谢物存在的数据将使我们能够可靠地确认扎来普隆、佐匹克隆、氯巴赞和非那西泮的摄入量,并确定受害者体内的给药(摄入)途径。苯二氮卓衍生物(氯巴唑和非苯二氮卓)和非苯二氮卓(扎来普隆和佐匹克隆)具有不同的化学结构和相似的作用机制,导致副作用的临床表现相似,需要根据中毒症状进行法医化学研究。测定口服苯二氮卓受体激动剂的代谢物及其在尿液中的比值:扎来普隆(母体化合物)、去乙基扎来普隆、5-氧唑扎来普隆、5-氧唑扎来普隆、氧唑扎来普隆葡萄糖醛酸盐;佐匹克隆(母体化合物)、佐匹克隆- n -氧化物、n -去甲基佐匹克隆;氯巴唑(母体化合物)、n -去甲基氯巴唑、4-羟基氯巴唑、羟去甲基氯巴唑;苯那西泮(母体化合物)和3-羟基苯那西泮。尿液中扎来普隆的测定建议采用5-奥沙来普隆(代谢物总量的97%),唑匹克隆为唑匹克隆- n -氧化物(尿液中86%),氯巴唑为母体化合物(尿液中61%),非那西泮为母体化合物(尿液中90-100%)。
期刊介绍:
The journal is concerned with the theory and practice of forensic medicine - the problems of thanatology, traumatology, toxicology, serology, forensic obstetrics, forensic dentistry, forensic psychiatry, forensic chemistry, physicotechnical methods of investigation, history of forensic medicine and some problems of criminology and legal laws related to forensic medicine. It publishes original studies by Russian authors, casuistry surveys, abstracts and reviews of Russian and foreign literature, scientific information, reports on scientific conferences.